Yıl: 2010 Cilt: 24 Sayı: 2 Sayfa Aralığı: 107 - 114 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Glikoproteinlerin yapısı ve fonksiyonları

Öz:
Glikoproteinler, bakteriden insana kadar pek çok canlıda bulunur ve farklı işlevlere sahiptir. Kısa oligosakkarit zincirlerine sahip bu proteinler pek çok hücresel olayda hormonlar, virüsler ve başka maddeler tarafından hücre yüzeyinin tanınmasında görev alırlar. Ayrıca hücre yüzey antijenleri, hücre dışı matriksin elemanı, gastrointestinal ve ürogenital yolun müsin salgısı olarak görev yaparlar. Bunların yanında albümin hariç plazmadaki globuler proteinlerin hemen hepsi, salgılanan enzimler ve proteinler glikoprotein yapısındadırlar. Bu derlemede glikoproteinlerin yapısı, fonksiyonları ve biyolojik önemi hakkında bilgi verilmiş, glikoproteinleri incelemede kullanılan yöntemlerden söz edilmiştir. Ayrıca, glikoproteinlerin klinik tedavide kullanılabilirliği ve kanserdeki önemi vurgulanmıştır.
Anahtar Kelime: yapı genel bakış kullanım yerleri kullanım etkinliği glikoprotein sınıflandırma

Konular: Veterinerlik

Structure and function of glycoproteins

Öz:
Glycoproteins exist in various organisms varying from bacteria to human, and they have many described functions. These proteins which have short oligosaccharides and serve in so many cellular events as cell surface recognition by hormones, viruses and other substances. They also serve as cell surface antigens, outer cell matriks element, mucine secretion of gastrointestinale and urogenitale tracts. Furthermore, almost all globuler proteins in plasma, except albumin, secreted enzymes and proteins are show glycoprotein structure. In this review, we have given information about structure, function and the biological significance of the glycoproteins and the main methods used in the examination of glycoproteins. The availability of glycoproteins in clinical treatments, and their significance in cancer were also highlighted.
Anahtar Kelime: use efficiency glycoproteins classification structure reviews uses

Konular: Veterinerlik
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Zubay GL, Parson WW, Yance DE. Principles of Biochemistry. 1st Edition, England: Wm. C. Brown Publishers 1994.
  • 2. Gabius HJ, Gabius S, Glycosciences, 1st Edition, Weinheim: Chapman&Hall 1997.
  • 3. Gottschalk A. Glycoproteins, 2nd Edition, Amsterdam: Elseiver Publishing Company 1972.
  • 4. Murray RK, Granner DK, Mayes, PA, Rodwell V.W. Harper’ın Biyokimyası. Dikmen N, Özgünen T (Çevirenler). 24. Baskı, İstanbul: Barış Kitabevi 1998.
  • 5. Hughes RC. Glycoproteins. London: Chapman and Hall.1983.
  • 6. Karaçalı S. Glikobiyoloji Güncel Moleküler Biyoloji. Turk J Vet Anim Sci 2003; 27: 489-495.
  • 7. Lisowska E. The role of glycosylation in protein antigenic properties. Cell Mol Life Sci 2002; 59: 445-455.
  • 8. Rao VSR, Qasaba PK, Balaji PV, Chandrasekeran R. Confirmation of Carbonhydrates. 1st Edition, Australia: Harwood Academic Publishers 1998.
  • 9. Champe PC, Harvey RA. Lippincott’s illustrated Review’s Serisinden Biyokimya. Tokullugil, A. (Çeviren). 2. Baskı, İstanbul: Nobel Tıp Kitabevleri 1994.
  • 10. Montogomery R, Conway TW, Spector AA, Chappell D. Biyokimya Olgu Sunumlu Yaklaşım. ALTAN, N. (Çeviren). 6. Baskı. Ankara: Palme Yayıncılık 1996.
  • 11. Yavuz. Ö. Glikoproteinler ve biyomedikal önemi. T Klin Tıp Bilimleri Dergisi 2001; 21: 517-522.
  • 12. Allen HJ, Kisailus EC. Glycoconjugates: Composition, Structure and Function. 1st Edition, New York: Marcell Dekker Inc 1992.
  • 13. Nelson DL, Michael MC. Carbonhydrates and Glycobiology. Kaçıncı baskı. Lehninger Principles of Biochemistry, United states of America: Word Publishers 2000.
  • 14. Elbein, A. Complex Carbonhydrates: Glycoproteins. 1st Edition, Medical Biochemistry, John Baynes, Marek H. Dominiczak. England: Mosby Publishing 1999.
  • 15. Kobata, A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 1992; 209; 483-501.
  • 16. Faillard, H. The early history of sialic acids, in proceedings of the Japanese-German Symposium on Sialic acids (Eds. Schauer R, Tamakawa T.) 1998; 6-18.
  • 17. Lennarz, WJ. The Biochemistry of Glycoproteins and Proteoglycans. Plenum Press 1980.
  • 18. Opdenakker G, Rudd P, Ponting C, Dweek R. Concepts and principles of glycobiology. FASEB J 1993; 7: 1330- 1337.
  • 19. Seyrek K, Bildik A. Lektinler. YYÜ Vet Fak Derg 2001; (1- 2): 96-100.
  • 20. Allen HJ, Kisailus EC. Glycoconjugates: Composition, Structure and Function. 1st Edition, New York: Marcell Dekker Inc 1992.
  • 21. Feizi, T. Cell-cell adhesion and membrane glycosilation. Curr Opin Struc Biol 1991; 1: 766-770.
  • 22. Akman Ş. Prion Hastalıklarının Patogenezine Biyokimyasal Yaklaşım. Gülhane Tıp Dergisi 2002; 44(2): 230-239.
  • 23. Hedrick JL. Comparative structural and antigenic properties of zona pellucida glycoproteins. J Reprod Fertill Suppl 1996; 50: 9-17.
  • 24. Hoke, D, Mebius R.E, Dybal N, et al. Selective modulation of the expression of L-selectin ligands by an immune response. Curr Biol 1995; 6: 670-678.
  • 25. Voynow JA. What does mucin have to do with lung disease? Pediatric Respiratory Reviews 2002; 3; 98-103.
  • 26. Chu TM. Biochemical markers of human cancer. Br J Cancer 1989; 59 :283-287.
  • 27. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999; 9: 67-81.
  • 28. Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006; 24 (10): 1241-1252.
  • 29. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science 2001; 291: 2370-2376.
  • 30. Zhang XL. Roles of glycans and glycopeptides in immune system and immune-related diseases. Curr Med Chem 2006; 13(10): 1141-1147.
  • 31. Nigam VN, Cantero A. Polysaccharides in cancer: Glycoproteins and glycolipids. Adv Cancer Res 1973; 17: 1-80.
  • 32. Schachter H., Jeaken J. Carbonhydrate-deficient glycoprotein syndrome type II. Biochim Biopys Acta 1999;1455(2-3): 179-192.
  • 33. Bussing A, Stein GM, Pfüller U, Schietsel M. Differential binding of toxic lectins from Viscum Album L, MLI and ML III, to humans lymphocytes. Anticancer Res 1999; 9(6b): 5095-5099
  • 34. Kuttan G, Menon LG. Anticarcinogenic and antimetastatic activity of Iscador Anticancer Drugs 1997; 8 :1515-1516.
  • 35. Van Huyen Sd,Bayry J. Induction of apoptosis of Endothelial cells by Viscum Album:a role for Anti-Tumoral properties of mistletoe lectins. Mol Med 2002; 8(10): 600- 606.
  • 36. Zarcovic N, Vucovıc T. An overview on anticancer activities of the Viscum Album extract Isorel Cancer Biother Radiopharm 2001; 16(1): 55-62.
  • 37. Choi SH, Lyu SY, Park WB. Mistletoe Lectin Induces Apoptosis and Telomerase Inhibition in Human A253 Cancer Cells through Dephosphorylation of Akt Arch Pharm Res 2004; 27(1): 68-76.
  • 38. Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B.) Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary nonmetastasized mammary carcinoma. Arzneimittelforschung 2004; 54(8): 456-466.
  • 39. Thies A, Dautel P, Meyer A, Pfüller U, Schumacher U. Low-dose mistletoe lectin-I reduces melanoma growth and spread in ascid mouse xenograft model. 1. Br J Cancer 2008; 15, 98(1): 106-112.
  • 40. Mejia Eg, Bradford T, Hasler C. The Anticarcinogenic Potential of Soybean Lectin and Lunasin. Nutr Rev 2003; 61(7): 239-246.
  • 41. Montreuil J, Vliegenthart JFG, Schachter H. Glycoproteins and Disease. Elsevier 1996.
  • 42. Brockhausen I. Clinical aspects of glycoprotein biosynthesis. Crit Rev Clin Lab Sci 1993; 30: 65- 151.
  • 43. Brockhausen I, Kuhns W. Role and metabolism of glycoconjugate sulfation. Trends Glycosci Glycotechnol 1997; 9: 379-398.
  • 44. Shamberger R.J. Evaluation of water soluble and lipid soluble sialic acid levels as tumor markers. Anticancer Research 1986; 6: 717-720.
  • 45. Brockhausen I, Yang J, Dickson N, Ogata S. Itzkowitz S. Mechanisms leading to the expression of the cancerassociated sialyl-Tn and Tn antigens in human cancer cells. Glycoconj J 1998; 15: 595-603
  • 46. Ye C, Kriyama K, Mistuoka C et al. Expression of Eselection on endothellal vells of small veins in human colorectal cancer. Int J Cancer 1995; 61: 455-460.
  • 47. Takahashi N, Lee KB, Nakagawa H, et al. Enzymatic sialylation of N-linked oligosaccharides using an α-(2.3)- specific transsialidase from Trypanosoma cruzi: Structural identification using a three-dimensional elution mapping technique. Anal Biochem 1995; 230: 333-342.
  • 48. Rademacher TW, Jones RH, Williams PJ. Significance and molecular basis for IgG glycosylation changes in rheumatoid arthritis. Adv Exp Med Biol 1995; 376:193-204.
  • 49. Erbil K, Jones J, Klee G. Use and Limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. Cancer 1985; 55: 404-409.
  • 50. Uysal H, Saxton J, Hemming FW. Changes in the secretion and glycosylation of fibronectin by human skin fibroblasts associated with tuberous sclerosis, Glycoconj J 1997; 14: 439-447.
  • 51. Uysal H, Hemming FW. Changes in the expression and distribution of fibronectin, laminin and tenascin by cultured fibroblasts of skin lesions of patients with tuberous sclerosis. Brit J Dermatol 1999; 141: 658-666.
  • 52. Schutter EMJ, Jelle JJ, Van Kamp GJ, et al.The utility of lipidassociated sialic acid (LASA or LSA) as a serum marker for malignancy. Tumor Biol 1992; 13: 121-132.
  • 53. Thougoard AV, Heilmen E, Pederson HD, Jensen AL. Correlation between α1-acid glikoprotein and total sialic acid in serum from dogs with tumours. J Vet Med A 1999; 46: 231-237.
  • 54. Sherblom PA, Smagula MR, Moody EC, Anderson WG. Immunosupression, sialic acid and sialytransferase of neonatal and maternal bovine serum. J Reprod Immunol 1986; 9: 365-375.
  • 55. Murali MB, Sundararas A, Nagarin B, Shanmugam V. Biochemical Markers in the diagnosis of 7th word Carcinoma in cattle. Indian Vet Journal 1993; 70: 14-16.
  • 56. Antony S, Kuttan R, Kuttan G. Role of natural killer cells in Iscador mediated inhibition of metastasis by adaptive Immunotherapy. Thrissur Immunol Invest 2000; 29 (3): 219-231.
APA UNUBOL AYPAK S, UYSAL H (2010). Glikoproteinlerin yapısı ve fonksiyonları. , 107 - 114.
Chicago UNUBOL AYPAK Serap,UYSAL Hamdi Glikoproteinlerin yapısı ve fonksiyonları. (2010): 107 - 114.
MLA UNUBOL AYPAK Serap,UYSAL Hamdi Glikoproteinlerin yapısı ve fonksiyonları. , 2010, ss.107 - 114.
AMA UNUBOL AYPAK S,UYSAL H Glikoproteinlerin yapısı ve fonksiyonları. . 2010; 107 - 114.
Vancouver UNUBOL AYPAK S,UYSAL H Glikoproteinlerin yapısı ve fonksiyonları. . 2010; 107 - 114.
IEEE UNUBOL AYPAK S,UYSAL H "Glikoproteinlerin yapısı ve fonksiyonları." , ss.107 - 114, 2010.
ISNAD UNUBOL AYPAK, Serap - UYSAL, Hamdi. "Glikoproteinlerin yapısı ve fonksiyonları". (2010), 107-114.
APA UNUBOL AYPAK S, UYSAL H (2010). Glikoproteinlerin yapısı ve fonksiyonları. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi, 24(2), 107 - 114.
Chicago UNUBOL AYPAK Serap,UYSAL Hamdi Glikoproteinlerin yapısı ve fonksiyonları. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi 24, no.2 (2010): 107 - 114.
MLA UNUBOL AYPAK Serap,UYSAL Hamdi Glikoproteinlerin yapısı ve fonksiyonları. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi, vol.24, no.2, 2010, ss.107 - 114.
AMA UNUBOL AYPAK S,UYSAL H Glikoproteinlerin yapısı ve fonksiyonları. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi. 2010; 24(2): 107 - 114.
Vancouver UNUBOL AYPAK S,UYSAL H Glikoproteinlerin yapısı ve fonksiyonları. Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi. 2010; 24(2): 107 - 114.
IEEE UNUBOL AYPAK S,UYSAL H "Glikoproteinlerin yapısı ve fonksiyonları." Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi, 24, ss.107 - 114, 2010.
ISNAD UNUBOL AYPAK, Serap - UYSAL, Hamdi. "Glikoproteinlerin yapısı ve fonksiyonları". Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi 24/2 (2010), 107-114.